IGF2BP3 and glioma: Furthermore, multivariate Cox regression analysis indicated that high expression of YTHDC2 served as an independent positive prognostic factor for overall survival, while elevated expression of IGF2BP3 acted as an independent negative prognostic factor for the overall survival of glioma patients [26].